Radiological Loco‑Regional Treatments for Cholangiocarcinoma: A Systematic Review of the Literature
Cholangiocarcinoma (CCA) is the second most common primary liver cancer and is being diagnosed with increasing frequency worldwide.
Cholangiocarcinoma (CCA) is the second most common primary liver cancer and is being diagnosed with increasing frequency worldwide.
The study provides a comprehensive synthesis of locoregional radiological therapies—such as percutaneous ablation (RFA, MWA, IRE), trans‑arterial chemoembolization (TACE) and selective internal radiation therapy (SIRT)—and their impact on overall survival, recurrence‑free survival, and candidate selection for patients with unresectable cholangiocarcinoma.
Evidence level: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Related signals
- The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
- Scientists build cell line atlas of deadly cancers of the bile ducts and gallbladder
- Cholangiocarcinoma Workup: Laboratory Studies, Imaging Studies, Procedures
- New EASL Clinical Practice Guidelines on extrahepatic cholangiocarcinoma
- An open‑label study of pemigatinib in cholangiocarcinoma: final results from FIGHT‑202